Microbot Medical Inc. (MBOT)

Microbot Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	4.04	4.13	5.55	5.2	5.69	4.19
Research & Development	5.28	5.72	7.74	6.15	3.4	3.05
Other Operating Expenses	0	0	0.01	0	0	0
Operating Expenses	9.32	9.86	13.29	11.36	9.09	7.24
Operating Income	-9.32	-9.86	-13.29	-11.36	-9.09	-7.24
Interest Expense / Income	0	0	0	0	0	0.1
Other Expense / Income	0.94	0.88	-0.12	-0.04	0.08	-0.1
Pretax Income	-10.26	-10.74	-13.17	-11.31	-9.17	-7.25
Net Income	-10.26	-10.74	-13.17	-11.31	-9.17	-7.25
Shares Outstanding (Basic)	14	10	7	7	7	4
Shares Outstanding (Diluted)	14	10	7	7	7	4
Shares Change	75.41%	40.49%	2.14%	-0.14%	66.80%	46.93%
EPS (Basic)	-0.89	-1.05	-1.81	-1.59	-1.29	-1.70
EPS (Diluted)	-0.89	-1.05	-1.81	-1.59	-1.29	-1.70
Free Cash Flow	-7.8	-8.57	-11.63	-9.42	-7.34	-6.41
Free Cash Flow Per Share	-0.56	-0.84	-1.60	-1.33	-1.03	-1.50
EBITDA	-10.15	-10.63	-13.07	-11.24	-9.1	-7.06
Depreciation & Amortization	0.11	0.11	0.1	0.08	0.07	0.08
EBIT	-10.26	-10.74	-13.17	-11.31	-9.17	-7.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).